Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Memorial Medical Center
351
mi
from 43215
Springfield, IL
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Memorial Medical Center
351
mi
from 43215
Springfield, IL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Neuroscience Research Institute
298
mi
from 43215
Winfield, IL
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Neuroscience Research Institute
298
mi
from 43215
Winfield, IL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Lake Charles Clinical Trials LLC
884
mi
from 43215
Lake Charles, LA
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Lake Charles Clinical Trials LLC
884
mi
from 43215
Lake Charles, LA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
John Hopkins Hospital
345
mi
from 43215
Baltimore, MD
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
John Hopkins Hospital
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
The Zucker Hillside Hospital
493
mi
from 43215
Glen Oaks, NY
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
The Zucker Hillside Hospital
493
mi
from 43215
Glen Oaks, NY
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati, Dept. of Psychiatry & Behavioral Neuroscience
98
mi
from 43215
Cincinnati, OH
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati, Dept. of Psychiatry & Behavioral Neuroscience
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Clínica Privada Banfield S.A
5394
mi
from 43215
Banfield,
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Clínica Privada Banfield S.A
5394
mi
from 43215
Banfield,
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
University of South Florida
822
mi
from 43215
Tampa, FL
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
University of South Florida
822
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Stony Brook University Medical Center
549
mi
from 43215
Stony Brook, NY
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Stony Brook University Medical Center
549
mi
from 43215
Stony Brook, NY
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Tennessee State University
255
mi
from 43215
Johnson City, TN
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Tennessee State University
255
mi
from 43215
Johnson City, TN
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
University of California San Diego/Psychiatry
1950
mi
from 43215
San Diego, CA
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
University of California San Diego/Psychiatry
1950
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Altea Research Institute
1759
mi
from 43215
Las Vegas, NV
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Altea Research Institute
1759
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Atlanta Behavioral Research, LLC
423
mi
from 43215
Atlanta, GA
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Atlanta Behavioral Research, LLC
423
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Medical Center
393
mi
from 43215
Madison, WI
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Medical Center
393
mi
from 43215
Madison, WI
Click here to add this to my saved trials
Behavior and Driving Safety Study
Behavior and Driving Safety Study
Status: Enrolling
Updated:  12/31/1969
Sacramento County Main Jail
2043
mi
from 43215
Sacramento, CA
Behavior and Driving Safety Study
Behavior and Driving Safety Study
Status: Enrolling
Updated: 12/31/1969
Sacramento County Main Jail
2043
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
A Closed-loop Assessment and Treatment Platform for Mood Disorders
A Closed-loop Assessment and Treatment Platform for Mood Disorders
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
A Closed-loop Assessment and Treatment Platform for Mood Disorders
A Closed-loop Assessment and Treatment Platform for Mood Disorders
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Open Trial of Behavioral Activation and Social Engagement (BASE) for Posttraumatic Stress Disorder (PTSD)
Open Trial of Behavioral Activation and Social Engagement (BASE) for Posttraumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  12/31/1969
VA Puget Sound Health Care System
2006
mi
from 43215
Seattle, WA
Open Trial of Behavioral Activation and Social Engagement (BASE) for Posttraumatic Stress Disorder (PTSD)
Open Trial of Behavioral Activation and Social Engagement (BASE) for Posttraumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 12/31/1969
VA Puget Sound Health Care System
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Evaluation of Web-Based CBT for Women Veterans With PTSD
Evaluation of Web-Based CBT for Women Veterans With PTSD
Status: Enrolling
Updated:  12/31/1969
VA Puget Sound Health Care System Seattle Division, Seattle, WA
2006
mi
from 43215
Seattle, WA
Evaluation of Web-Based CBT for Women Veterans With PTSD
Evaluation of Web-Based CBT for Women Veterans With PTSD
Status: Enrolling
Updated: 12/31/1969
VA Puget Sound Health Care System Seattle Division, Seattle, WA
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Facilitating the Behavioral Treatment of Cannabis Use Disorder
Facilitating the Behavioral Treatment of Cannabis Use Disorder
Status: Enrolling
Updated:  12/31/1969
NYSPI
477
mi
from 43215
New York, NY
Facilitating the Behavioral Treatment of Cannabis Use Disorder
Facilitating the Behavioral Treatment of Cannabis Use Disorder
Status: Enrolling
Updated: 12/31/1969
NYSPI
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Neuroendocrine Response to Oral Alcohol Administration
Neuroendocrine Response to Oral Alcohol Administration
Status: Enrolling
Updated:  12/31/1969
Yale University
537
mi
from 43215
New Haven, CT
Neuroendocrine Response to Oral Alcohol Administration
Neuroendocrine Response to Oral Alcohol Administration
Status: Enrolling
Updated: 12/31/1969
Yale University
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Neurofeedback With Real-Time fMRI for Treatment of PTSD
Neurofeedback With Real-Time fMRI for Treatment of Posttraumatic Stress Disorder
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Neurofeedback With Real-Time fMRI for Treatment of PTSD
Neurofeedback With Real-Time fMRI for Treatment of Posttraumatic Stress Disorder
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
Status: Enrolling
Updated:  12/31/1969
New York State Psychiatric Institute
481
mi
from 43215
New York, NY
Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
Status: Enrolling
Updated: 12/31/1969
New York State Psychiatric Institute
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
MR Guided Focused Ultrasound for Treatment of Neuropathic Pain
Phase 1 Clinical Trial for MR Guided Focused Ultrasound (FUS) Thalamotomy of Central Lateral Thalamic Nucleus for the Treatment of Neuropathic Pain
Status: Enrolling
Updated:  12/31/1969
University of Maryland School of Medicine and University of Maryland Medical Systems
343
mi
from 43215
Baltimore, MD
MR Guided Focused Ultrasound for Treatment of Neuropathic Pain
Phase 1 Clinical Trial for MR Guided Focused Ultrasound (FUS) Thalamotomy of Central Lateral Thalamic Nucleus for the Treatment of Neuropathic Pain
Status: Enrolling
Updated: 12/31/1969
University of Maryland School of Medicine and University of Maryland Medical Systems
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Soberlink - MAP Outcomes Study Protocol
Soberlink - MAP Outcomes Study Protocol
Status: Enrolling
Updated:  12/31/1969
MAP Health Management LLC
1068
mi
from 43215
Austin, TX
Soberlink - MAP Outcomes Study Protocol
Soberlink - MAP Outcomes Study Protocol
Status: Enrolling
Updated: 12/31/1969
MAP Health Management LLC
1068
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Integration of Musculoskeletal Physical Therapy Care in the Patient Centered Medical Home
Integration of Musculoskeletal Physical Therapy Care in the Patient Centered Medical Home
Status: Enrolling
Updated:  12/31/1969
Duke Outpatient Clinic
351
mi
from 43215
Durham, NC
Integration of Musculoskeletal Physical Therapy Care in the Patient Centered Medical Home
Integration of Musculoskeletal Physical Therapy Care in the Patient Centered Medical Home
Status: Enrolling
Updated: 12/31/1969
Duke Outpatient Clinic
351
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Nurse and Physician Stress Reduction: Learning Receptive Awareness Via EEG Feedback
Nurse and Physician Stress Reduction: Learning Receptive Awareness Via EEG Feedback
Status: Enrolling
Updated:  12/31/1969
St Elizabeth Youngstown Hospital
147
mi
from 43215
Youngstown, OH
Nurse and Physician Stress Reduction: Learning Receptive Awareness Via EEG Feedback
Nurse and Physician Stress Reduction: Learning Receptive Awareness Via EEG Feedback
Status: Enrolling
Updated: 12/31/1969
St Elizabeth Youngstown Hospital
147
mi
from 43215
Youngstown, OH
Click here to add this to my saved trials
Neuroimaging During Pure Oxygen Breathing
Hyperoxia: An Unrecognized Mechanism for Inducing "Hypoxia-Like" Symptoms
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve Univ
129
mi
from 43215
Cleveland, OH
Neuroimaging During Pure Oxygen Breathing
Hyperoxia: An Unrecognized Mechanism for Inducing "Hypoxia-Like" Symptoms
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Cognitive Remediation Therapy for Adolescents With Anorexia Nervosa
An Investigation of Cognitive Remediation Therapy as an Inpatient Intervention for Adolescents With Anorexia Nervosa
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Cognitive Remediation Therapy for Adolescents With Anorexia Nervosa
An Investigation of Cognitive Remediation Therapy as an Inpatient Intervention for Adolescents With Anorexia Nervosa
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
RAGE-Control: Teaching Emotional Self-regulation Through Videogame Play
RAGE-Control: Teaching Emotional Self-regulation Through Videogame Play
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
RAGE-Control: Teaching Emotional Self-regulation Through Videogame Play
RAGE-Control: Teaching Emotional Self-regulation Through Videogame Play
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Stress-Busting Program and QoL, Bio-markers of Immunity/Stress and Cellular Aging
Effect of Stress-Busting Program on Caregivers' Quality of Life, Stress/Immunity Bio-markers, and Cellular Aging
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at San Antonio
1137
mi
from 43215
San Antonio, TX
Stress-Busting Program and QoL, Bio-markers of Immunity/Stress and Cellular Aging
Effect of Stress-Busting Program on Caregivers' Quality of Life, Stress/Immunity Bio-markers, and Cellular Aging
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at San Antonio
1137
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Entolimod, an Adjuvant for Vaccine Augmentation
Entolimod, an Adjuvant for Vaccine Augmentation
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Entolimod, an Adjuvant for Vaccine Augmentation
Entolimod, an Adjuvant for Vaccine Augmentation
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
REACH VET Program Evaluation
Risk Stratified Enhancements to Clinical Care: Targeting Care for Patients Identified Through Predictive Modeling as Being at High Risk for Suicide, With the Office of Mental Health Operations
Status: Enrolling
Updated:  12/31/1969
Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
622
mi
from 43215
North Little Rock, AR
REACH VET Program Evaluation
Risk Stratified Enhancements to Clinical Care: Targeting Care for Patients Identified Through Predictive Modeling as Being at High Risk for Suicide, With the Office of Mental Health Operations
Status: Enrolling
Updated: 12/31/1969
Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
622
mi
from 43215
North Little Rock, AR
Click here to add this to my saved trials
REACH VET Program Evaluation
Risk Stratified Enhancements to Clinical Care: Targeting Care for Patients Identified Through Predictive Modeling as Being at High Risk for Suicide, With the Office of Mental Health Operations
Status: Enrolling
Updated:  12/31/1969
VA Eastern Colorado Health Care System, Denver, CO
1162
mi
from 43215
Denver, CO
REACH VET Program Evaluation
Risk Stratified Enhancements to Clinical Care: Targeting Care for Patients Identified Through Predictive Modeling as Being at High Risk for Suicide, With the Office of Mental Health Operations
Status: Enrolling
Updated: 12/31/1969
VA Eastern Colorado Health Care System, Denver, CO
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Nitrous TRD Bipolar Depression
Nitrous Oxide - A Novel Therapy for Treatment-Resistant Bipolar Depression
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Nitrous TRD Bipolar Depression
Nitrous Oxide - A Novel Therapy for Treatment-Resistant Bipolar Depression
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
WILD 5 Wellness: A 90-Day Intervention (WILD = Wellness Interventions for Life's Demands)
WILD 5 Wellness: A 90-Day Intervention (WILD = Wellness Interventions for Life's Demands)
Status: Enrolling
Updated:  12/31/1969
University of Texas at Austin School of Nursing
1064
mi
from 43215
Austin, TX
WILD 5 Wellness: A 90-Day Intervention (WILD = Wellness Interventions for Life's Demands)
WILD 5 Wellness: A 90-Day Intervention (WILD = Wellness Interventions for Life's Demands)
Status: Enrolling
Updated: 12/31/1969
University of Texas at Austin School of Nursing
1064
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Iwin: Individual Well-Being Navigator
iWin: Navigating Your Path to Well-Being
Status: Enrolling
Updated:  12/31/1969
RallyPoint.com
637
mi
from 43215
Watertown, MA
Iwin: Individual Well-Being Navigator
iWin: Navigating Your Path to Well-Being
Status: Enrolling
Updated: 12/31/1969
RallyPoint.com
637
mi
from 43215
Watertown, MA
Click here to add this to my saved trials
Iwin: Individual Well-Being Navigator
iWin: Navigating Your Path to Well-Being
Status: Enrolling
Updated:  12/31/1969
Military Media Inc.
494
mi
from 43215
Poughkeepsie, NY
Iwin: Individual Well-Being Navigator
iWin: Navigating Your Path to Well-Being
Status: Enrolling
Updated: 12/31/1969
Military Media Inc.
494
mi
from 43215
Poughkeepsie, NY
Click here to add this to my saved trials
Iwin: Individual Well-Being Navigator
iWin: Navigating Your Path to Well-Being
Status: Enrolling
Updated:  12/31/1969
Pro-Change Behavior Systems, Inc.
609
mi
from 43215
South Kingstown, RI
Iwin: Individual Well-Being Navigator
iWin: Navigating Your Path to Well-Being
Status: Enrolling
Updated: 12/31/1969
Pro-Change Behavior Systems, Inc.
609
mi
from 43215
South Kingstown, RI
Click here to add this to my saved trials
Iwin: Individual Well-Being Navigator
iWin: Navigating Your Path to Well-Being
Status: Enrolling
Updated:  12/31/1969
Pilot Media
422
mi
from 43215
Norfolk, VA
Iwin: Individual Well-Being Navigator
iWin: Navigating Your Path to Well-Being
Status: Enrolling
Updated: 12/31/1969
Pilot Media
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Occupational Therapy Driving Intervention for Returning Combat Veterans.
Efficacy of a Driving Program on Safe Community Mobility for Combat Veterans
Status: Enrolling
Updated:  12/31/1969
Malcom Randall VA Medical Center
716
mi
from 43215
Gainesville, FL
Occupational Therapy Driving Intervention for Returning Combat Veterans.
Efficacy of a Driving Program on Safe Community Mobility for Combat Veterans
Status: Enrolling
Updated: 12/31/1969
Malcom Randall VA Medical Center
716
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Occupational Therapy Driving Intervention for Returning Combat Veterans.
Efficacy of a Driving Program on Safe Community Mobility for Combat Veterans
Status: Enrolling
Updated:  12/31/1969
University of Florida
714
mi
from 43215
Gainesville, FL
Occupational Therapy Driving Intervention for Returning Combat Veterans.
Efficacy of a Driving Program on Safe Community Mobility for Combat Veterans
Status: Enrolling
Updated: 12/31/1969
University of Florida
714
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Digital Star: HIV Prevention for Youth in Mental Health Treatment
Digital Star: HIV Prevention for Youth in Mental Health Treatment
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
619
mi
from 43215
Providence, RI
Digital Star: HIV Prevention for Youth in Mental Health Treatment
Digital Star: HIV Prevention for Youth in Mental Health Treatment
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Postoperative Delirium: Brain Vulnerability and Recovery
Postoperative Delirium: Brain Vulnerability and Recovery
Status: Enrolling
Updated:  12/31/1969
Barnes Jewish Hospital / Washington University in St. Louis School of Medicine
397
mi
from 43215
Saint Louis, MO
Postoperative Delirium: Brain Vulnerability and Recovery
Postoperative Delirium: Brain Vulnerability and Recovery
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital / Washington University in St. Louis School of Medicine
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD
Phase II, Open-label, Dose-titration, Safety Study Designed to Determine the Evening Dose of a Novel Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) to Produce Optimal Clinical Effects in Children With ADHD
Status: Enrolling
Updated:  12/31/1969
Center for Psychiatry and Behavioral Medicine, Inc.
1762
mi
from 43215
Las Vegas, NV
A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD
Phase II, Open-label, Dose-titration, Safety Study Designed to Determine the Evening Dose of a Novel Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) to Produce Optimal Clinical Effects in Children With ADHD
Status: Enrolling
Updated: 12/31/1969
Center for Psychiatry and Behavioral Medicine, Inc.
1762
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Laboratory Classroom Study to Evaluate the Safety and Efficacy of PRC-063 Compared to Placebo in Children (6-12 Years of Age) With ADHD
Status: Enrolling
Updated:  12/31/1969
AVIDA, Inc.
1963
mi
from 43215
Newport Beach, CA
PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Laboratory Classroom Study to Evaluate the Safety and Efficacy of PRC-063 Compared to Placebo in Children (6-12 Years of Age) With ADHD
Status: Enrolling
Updated: 12/31/1969
AVIDA, Inc.
1963
mi
from 43215
Newport Beach, CA
Click here to add this to my saved trials
PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Laboratory Classroom Study to Evaluate the Safety and Efficacy of PRC-063 Compared to Placebo in Children (6-12 Years of Age) With ADHD
Status: Enrolling
Updated:  12/31/1969
Meridien Research
861
mi
from 43215
Bradenton, FL
PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Laboratory Classroom Study to Evaluate the Safety and Efficacy of PRC-063 Compared to Placebo in Children (6-12 Years of Age) With ADHD
Status: Enrolling
Updated: 12/31/1969
Meridien Research
861
mi
from 43215
Bradenton, FL
Click here to add this to my saved trials
PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Laboratory Classroom Study to Evaluate the Safety and Efficacy of PRC-063 Compared to Placebo in Children (6-12 Years of Age) With ADHD
Status: Enrolling
Updated:  12/31/1969
Meridien Research, Inc.
788
mi
from 43215
Maitland, FL
PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Laboratory Classroom Study to Evaluate the Safety and Efficacy of PRC-063 Compared to Placebo in Children (6-12 Years of Age) With ADHD
Status: Enrolling
Updated: 12/31/1969
Meridien Research, Inc.
788
mi
from 43215
Maitland, FL
Click here to add this to my saved trials
PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Laboratory Classroom Study to Evaluate the Safety and Efficacy of PRC-063 Compared to Placebo in Children (6-12 Years of Age) With ADHD
Status: Enrolling
Updated:  12/31/1969
QPS MRA
997
mi
from 43215
Miami, FL
PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Laboratory Classroom Study to Evaluate the Safety and Efficacy of PRC-063 Compared to Placebo in Children (6-12 Years of Age) With ADHD
Status: Enrolling
Updated: 12/31/1969
QPS MRA
997
mi
from 43215
Miami, FL
Click here to add this to my saved trials
PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Laboratory Classroom Study to Evaluate the Safety and Efficacy of PRC-063 Compared to Placebo in Children (6-12 Years of Age) With ADHD
Status: Enrolling
Updated:  12/31/1969
Center for Psychiatry and Behavioral Medicine, Inc.
1762
mi
from 43215
Las Vegas, NV
PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Laboratory Classroom Study to Evaluate the Safety and Efficacy of PRC-063 Compared to Placebo in Children (6-12 Years of Age) With ADHD
Status: Enrolling
Updated: 12/31/1969
Center for Psychiatry and Behavioral Medicine, Inc.
1762
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials